Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Tolerability of Raxibacumab in Healthy Subjects
NCT00639678Phase 3Completed
- Sponsor
- Human Genome Sciences
- Start
- Mar 2008
- Primary completion
- Jul 2008
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
01
Overview
A Phase 3 trial of Raxibacumab in inhalational anthrax, sponsored by Human Genome Sciences. Started Mar 2008; status: completed.
02
Drugs
Raxibacumab
03
Conditions
inhalational anthrax
Beyond the preview
Go deeper on NCT00639678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00639678.